Carlisle Companies Incorporated (CSL)
$420.03 -$2.08 (-0.49%) 4:40 PM 12/13/24
NYSE | $USD | Building Products & EquipmentStock Data
-
Market Cap
$19.94B -
Day's Range
$416.72 - $422.46 -
Volume
300,773 -
52 Week Low / High
$288.57 - $480.19 -
PE Ratio
23.58x -
PEG Ratio
1.26 -
Dividend Frequency
quarterly
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 3
- Strong Buy
- 1
- Buy
- 3
- Hold
- 0
- Sell
- 0
- Strong Sell
- $311.25
- Target Price
Company News
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024
Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....
-
UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024
Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024
Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....
-
UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024
Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024
Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....
-
UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024
Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024
Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024
Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
Carlisle Companies Expands with Plasti-Fab Acquisition — Oct 19th, 2024
https://www.tipranks.com/news/company-announcements/united-airlines-faces-uncertainty-in-share-repurchase-program-impacting-stockholder-value The latest update is out from Carlisle Companies ( (CSL) ). Carlisle Companies is set to expand its influence in the North American expanded polys...
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024
The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024
Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024
Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....
-
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024
Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
-
Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024
Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....
Portfolio
Comprised of 1 portfolios